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An important issue for immunologists is the
difference between the two main processes that
determine the mature repertoire of T-cell receptors,
termed positive and negative selection. Recent papers
have addressed the role of self-peptides in the
process of positive selection.
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A key question in immunology is the difference between
two processes that govern the maturation of T cells in the
thymus. These processes are called positive and negative
intrathymic selection. Both involve the recognition of self-
peptides bound to self major histocompatibility complex
(MHC) molecules, but the outcome of the two processes is
as radically different as their names suggest. Positive selec-
tion rescues a small population (less than 5%) of develop-
ing thymocytes from programmed cell death [1]. Negative
selection then acts on this population to remove a further
percentage of T cells bearing receptors that would be stim-
ulated by self-peptide–self-MHC complexes in the
periphery and could thereby induce autoimmunity [2].
Estimates for the loss of thymocytes at this step range
from 5 to 70%, depending on the method of determination
[3–8]. How this gauntlet is negotiated by a given T cell,
and how the extensive repertoire of mature T-cell recep-
tors is sustained in the periphery, are questions that have
puzzled and fascinated immunologists, biochemists, crys-
tallographers, and many other scientists since the mid-
1970s. Recently, two studies [9,10] have examined the role
of self-peptides in positive selection and have essentially
reached the same conclusion: positive selection of each
T cell requires a limited set of specific self-peptides. 
Earlier attempts to examine this issue relied upon the
culture of fetal thymuses (fetal thymic organ culture) from
mice that lacked cell-surface expression of MHC class I
molecules due to the deletion of the gene encoding the β2
microglobulin component of the MHC class I molecule or
deletion of the gene for the transporter associated with
antigen processing (TAP). The absence of MHC class I
molecules in these mice resulted in the inhibition of the
generation of mature CD8 T cells, which requires interac-
tion between the T-cell receptors and peptide–MHC class
I complexes. To these cultures, differing amounts or dif-
fering sequences of peptides were added in the presence
of β2 microglobulin to restore surface expression of MHC
class I molecules and allow CD8 T cells to be generated.
Although in certain cases a single peptide could generate
up to 20% of the normal numbers of CD8 T cells, in
general, the more complex the mixture of peptides, the
greater the number of CD8 T cells generated. The most
effective peptides that drove this positive selection in
culture turned out to be a mixture of peptides eluted from
the thymus [11,12].
In subsequent experiments [13–16], specific peptides
were added to fetal thymic organ cultures derived from
mice lacking β2 microglobulin or TAP and were used to
select specific T cells bearing individual T-cell receptors.
From these studies, it was concluded that peptides with
the ability to stimulate T cells led to inactivation or elimi-
nation of the T cells, whereas peptides that could not
stimulate T cells could, depending on their sequence,
induce positive selection of activatable CD8 T cells
[13–16]. Recently, two groups succeeded in isolating natu-
rally occurring self-peptides that could drive positive
selection of CD8 T cells [17,18]. Sequencing of these pep-
tides revealed that they did not resemble the antigenic,
stimulatory peptide or its positively selecting variants.
Furthermore, one of the reports detected eight self-pep-
tides that could mediate positive selection of clonal
T cells expressing a single specific T-cell receptor, imply-
ing that there is significant degeneracy in the peptide
component of positive selection. From this it was con-
cluded that positive intrathymic selection was only par-
tially specific for peptide, and that many different
peptides in the thymus could select T cells expressing a
given T-cell receptor. Thus, positive selection of CD8 T
cells involves recognition of anything from one to more
than eight peptides derived from self.
But what conditions induced positive selection of CD4
T cells, which recognize peptides bound to MHC class II
molecules? This problem was approached in a similar way,
using mice lacking various molecules required for peptide
presentation by MHC class II molecules, namely the MHC
class II invariant chain (Ii), which directs newly synthe-
sized MHC class II molecules to the correct intracellular
compartments for peptide binding, and H-2M, the MHC
class II peptide-exchange factor. In the case of mice
lacking Ii, CD4 T cells were weakly positively selected,
because MHC class II molecules were present at very low
levels in all tissues including the thymus [19]. In the case
of mice lacking H-2M, the levels of surface MHC class II
were somewhat decreased, and most of the MHC class II
that was expressed on the surface of cells was bound to a
single peptide called CLIP, for class II associated invariant
chain peptide (a short peptide fragment derived from Ii
that must be displaced from MHC class II molecules
before they can present processed peptides). CLIP was
identified as a naturally occurring self-peptide by elution
from the MHC class II molecule I-Ab [20]. The Ii-deficient
mice were crossed with mice lacking the β chain of I-Ab,
resulting in offspring that were completely deficient in
MHC class II expression. These mice were then them-
selves crossed with mice expressing a single specific cova-
lent peptide–MHC complex comprising the β chain of the
I-Ab molecule bound to a peptide, Eα52–6, derived from
the non-polymorphic α chain of the I-E MHC class II mol-
ecule: the resulting offspring present this one specific
peptide on their cells [6,19]. 
About one-third to one-half of the normal number of CD4
T cells were positively selected in both the CLIP and the
Eα52–68 ‘single-peptide’ mice. The distribution of T-cell
receptor β chains expressed on the T cells of these mice
was almost normal, suggesting that these mice had a
diverse repertoire of T-cell receptors. Both kinds of mice,
however, showed a marked ‘skewing’ in their response to
cells from mice of the same MHC genotype, I-Ab, with up
to 70% of T cells recognizing I-Ab-bearing cells that pre-
sented a normal cargo of self-peptides. From these results,
two conclusions were drawn. The first was that a single
peptide could select a very diverse repertoire of T-cell
receptors, as shown by the normal distribution of T-cell
receptor β chains. The second was that negative selection
played a major role in shaping the mature T-cell receptor
repertoire, because up to 70% of the cells selected on one
peptide bound to I-Ab would have to be deleted under
normal conditions in order to maintain self-tolerance.
In following up these conclusions, several groups crossed
the H-2M-deficient mice with mice expressing various
T-cell receptors that had been positively selected with
I-Ab–peptide complexes, and found that none of these T-
cell receptors could be positively selected if H-2M was
absent [8]. Moreover, when H-2M-deficient mice were
crossed with transgenic mice engineered to express a par-
ticular T-cell receptor β chain [21], an equivalent number
of CD4 T cells was found in the thymus and peripheral
lymphoid organs of the resulting offspring as that found in
H-2M-deficient mice expressing the full range of endoge-
nous T-cell receptor β chains. This finding proved that
diversity in T-cell receptor β chains was not an adequate
measure of T-cell receptor diversity. Indeed, the H-2M-
deficient, T-cell receptor β chain transgenic mice mani-
fested an equivalent high-frequency response to I-Ab
presenting a normal load of self-peptide as did mice with a
full complement of T-cell receptor β chains, demonstrat-
ing that this I-Ab-reactive repertoire was independent of
the sequence of the T-cell receptor β chain. Finally,
sequence analysis of the accompanying T-cell receptor α
chains showed that there was a marked constraint in the
length and sequence of the T-cell receptor α chain (a hall-
mark of a positively selected cell) in the absence, but not
the presence, of H-2M. These results strongly indicated
that most T cells selected in H-2M-deficient mice were
positively selected by the CLIP peptide. A related study
by Grubin et al. [22] showed that antibodies to I-Ab that
did not react with the I-Ab–CLIP complex (and therefore
reacted with I-Ab bound to other peptides) were neverthe-
less able to reduce the numbers of CD4 T cells that were
positively selected. Taken together, these data therefore
suggest that both CLIP and non-CLIP peptides are
involved in positive selection in H-2M-deficient mice.
Whether positive selection in mice engineered to express a
single, dominant peptide is driven only by that particular
peptide, or whether other peptides can also contribute to
the selection process was the question that Barton and
Rudensky [9] aimed to answer. These investigators had
previously shown that by replacing the CLIP sequence in
the Ii chain with the Eα52–68 sequence (creating
Ii–Eα52–68) and expressing this chain in Ii-deficient mice,
they could reliably observe very high levels of binding of
the monoclonal antibody Y-Ae — specific for I-Ab mole-
cules bound to the Eα52–68 peptide [23]. These mice
were then crossed with mice that lacked H-2M expression,
and T-cell development was examined in the Ii–Eα52–68,
Ii-deficient transgenic mice and in the Ii–Eα52–68,
Ii-deficient, H-2M-deficient (double-deficient) mice. 
The authors observed a significant inhibition of CD4
T-cell development in the thymus and peripheral lym-
phoid tissues of the Ii–Eα52–68, double-deficient mice.
More importantly, they could inhibit T-cell development
in fetal thymic organ culture with a monoclonal antibody
directed at I-Ab that recognizes most cell-surface I-Ab
molecules in all mice of the H-2b MHC genotype;
however, they could not inhibit T-cell development with
the Y-Ae antibody — which bound to most surface I-Ab
molecules in these particular mice — whether the mice
were deficient in Ii alone or in both Ii and H-2M. One
caveat in these results is that the Y-Ae antibody is known
to be able to inhibit negative selection in mice expressing
the Y-Ae epitope and a T-cell receptor that recognizes
this epitope (C. Viret and C.A.J., unpublished observa-
tions). Thus, the absence of inhibition by Y-Ae in the
fetal thymic organ culture system may reflect a balance of
inhibition of negative as well as positive selection, which
would appear functionally as having no overall effect.
This might be analyzed in terms of the strength of
binding of the T-cell receptors to the I-Ab–Eα52–68
complex by T cells raised in the presence or absence of
Y-Ae (Figure 1). 
A different approach was also reported recently by Baldwin
et al. [10]. This group used monoclonal antibodies that
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bound to the complex comprising the MHC class II mole-
cule I-Ek bound to the peptide corresponding to residues
88–103 of moth cytochrome c. Several monoclonal antibod-
ies specific for this complex were injected individually into
pregnant females from day 15 of gestation: the authors
found decreased numbers of CD4 T cells in mice injected
with one particular monoclonal antibody that bound to the
carboxy-terminal residues of the moth cytochrome c
peptide and to residues in I-Ek adjacent to the peptide in
the complex. They demonstrated that the inhibition of pos-
itive selection by this monoclonal antibody was partial. Fur-
thermore, they showed that the monoclonal antibody could
be used to isolate several peptides from the thymus. The
identity of these peptides is unknown, and the remaining
positive selection seen in the presence of the monoclonal
antibody suggests that further peptides that are involved in
positive selection, but cannot be bound by the monoclonal
antibody, may be present, at least on thymic epithelial cells.
Taken together, the studies of Barton and Rudensky [9],
Baldwin et al. [10] and Sant’Angelo et al. [21] indicate that
self-peptides specifically direct the process of positive
selection. This finding is further reinforced by earlier
results from mice deficient in cathepsin L; these mice
have a diminished expression of self-peptides that leads to
a decrease in positive selection of CD4 T cells [24]. These
studies also suggest that there are multiple self-peptides
that can positively select CD4 T cells, exactly as was
found in the systems that examined positive selection in
CD8 T cells. Thus, the first part of the mystery surround-
ing CD4 T-cell development can be answered — positive
intrathymic selection of individual CD4 T cells is specific
for several distinct self-peptide–self-MHC class II com-
plexes, as is negative intrathymic selection. How the pep-
tides differ for these two selection processes, whether the
difference is quantitative or qualitative, and whether there
is a limited diversity in thymic self-peptides that drive
positive selection are difficult problems that remain to be
answered. Nevertheless, we can take comfort in the
knowledge that both classes of MHC molecule use several
bound self-peptides to induce positive intrathymic selec-
tion of both CD4 and CD8 T cells.
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Figure 1
(a) Thresholds for selection events in the thymus of Ii–Eα52–68 mice
at the pre-selection stage. The effects of increasing concentrations of
I-Ab–Eα52–68 on thymocyte number are shown. (b) The effects of the
Y-Ae monoclonal antibody on selection in the thymus of these mice.
Barton and Rudensky [9] found no effect on positive selection of
T cells in the presence or absence of the Y-Ae monoclonal antibody
which binds to virtually all of the MHC–peptide complexes expressed
on the cells of the Ii–Eα52–68 mice. A possible explanation for this is
shown, whereby the Y-Ae antibody effectively increases the thresholds
for both positive and negative intrathymic selection by lowering the
number of I-Ab–Eα52–68 complexes available to the T-cell receptor.
One would predict that cells with this increased threshold would
respond to Y-Ae-positive stimulator cells upon co-culture in a mixed
lymphocyte reaction if this model is correct.
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If you found this dispatch interesting, you might also want
to read the April 1999 issue of
Current Opinion in
Immunology 
which included the following reviews, edited
by David Nemazee and BJ Fowlkes, on
Lymphocyte development:
Development and tolerance of natural killer cells
David H Raulet
Pleiotropic changes controlled by the pre-T-cell
receptor
Harald von Boehmer, Iannis Aifantis, Jacqueline Feinberg,
Oskar Lechner, Claude Saint-Ruf, Ulrich Walter, Jan Buer
and Orly Azogui
B cell development: signal transduction by antigen
receptors and their surrogates
Robert J Benschop and John C Cambier
Peripheral T cell survival
Antonio A Freitas and Benedita Rocha
The role of cytokine receptor signaling in 
lymphocyte development
Allison M Baird, Rachel M Gerstein and Leslie J Berg
Control of lymphocyte development by the Ikaros 
gene family
Marta Cortes, Esther Wong, Joseph Koipally 
and Katia Georgopoulos
B cell memory and the long-lived plasma cell
Michael G McHeyzer-Williams and Rafi Ahmed
Helper T cell differentiation
Susan L Swain
Hypermutation in antibody affinity maturation
Matthias Wabl, Marilia Cascalho and Charles Steinberg
the same issue also included the following
reviews, edited by Søren Buus, on
Immunological techniques:
Specificity of the proteasome and the TAP transporter
Stephen Uebel and Robert Tampé
Description and prediction of peptide–MHC binding:
the ‘human MHC project’
Søren Buus
The full text of Current Opinion in Immunology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/imm
